For research and visualization only. Not financial advice.

About·Sitemap·RSS·llms.txt·Updated daily

Browse voices by sector:Long Research Situational Semis Software Energy Biotech Short Sellers Quant / Flow Macro Crypto·Most active voices

$SNY — FinTwit mentions on Surfaced

Home/$SNY

Last 12mo stats

mentions

voices

$SNY

Sanofi

Share on X

$SNY

·Sanofi

Past 12mo:18mentions·2voices

Share on X

All voices5 calls since Jul 2025show all

Loading price chart…

Recent calls

5 calls

Frequently asked

Who mentions $SNY most on Surfaced?+

@jacobplieth (Jacob Plieth) mentions $SNY most — 11 mentions in the past 12 months.

When was $SNY first mentioned on Surfaced?+

The earliest tracked mention of $SNY in the Surfaced archive was on Jun 20, 2025.

How many voices track $SNY?+

2 FinTwit voices have mentioned $SNY 18 times in the past 12 months.

What kind of voices mention $SNY most?+

$SNY is mentioned most by Biotech voices on Surfaced.

Related stocks

$ABBVAbbVie

$ALLOAllogene Therapeutics

$AMGNAMGEN

$ARVNArvinas

Explore $SNYFull mention timeline All voices who mention $SNY RSS feed Who mentions $SNY most Who called $SNY first

@adamfeuersteinFeb 12, 2026 · 10:48 AM

Paul Hudson out as Sanofi $SNY CEO https://t.co/HSxdB1PshV via @DrewQJoseph

Open on X

@jacobpliethJan 29, 2026 · 3:22 PM

Looks like $SNY discontinued Alphamedix/ SAR447873, licensed in Sep 2024 from Radiomedix & Orano Med, h/t B Riley. @ByMadeleineA covered it at #Esmo25 and flagged dysphagia & renal tox. https://t.co/6L2O0c5cOA Good news for $CATX?

Open on X

@adamfeuersteinJan 23, 2026 · 12:23 PM

Perhaps I am over-reacting, but doesn't the reported case of Kaposi's sarcoma in the $SNY amlitelimab atopic dermatitis study basically end any hope for the entire OX40 drug class? $AMGN included. Why would any patient or physician take the risk with an OX40 drug when there are so many other better treatment options?

Open on X

@adamfeuersteinSep 4, 2025 · 10:37 AM

Sanofi $SNY shares drop after disappointing trial results. Amlitelimab falls short against Dupixent in atopic dermatitis. https://t.co/SJNDXMIIKd via @DrewQJoseph

Open on X

@adamfeuersteinJul 22, 2025 · 10:07 AM

Sanofi $SNY to buy vaccine biotech Vicebio for $1.15B upfront https://t.co/Vn6nfm792T via @DrewQJoseph

Open on X

$ARWR

Arrowhead Pharmaceuticals

$ATRAAtara Biotherapeutics

$BIIBBiogen

$BNTXBioNTech SE